Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Aug 2026 for UroGen Pharma Ltd., €2.5M.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Schoenberg Mark: trading record in brief
All filings by Schoenberg Mark on record concern UroGen Pharma Ltd. The record holds 4 filings, for trades running from 8 June 2026 to 20 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 20 August 2026, reports a transaction of €2.5M in UroGen Pharma Ltd. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Schoenberg Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
60,677 shares@ US$47.6662COMMONSEC144:0001000275-26-000100
10,000 shares@ US$40.00080.017% mcap32.1% of flowCOMMONSEC144:0001000275-26-000093
10,000 shares@ US$35.01430.015% mcap14.3% of flowCOMMONSEC144:0001000275-26-000079
5,222 shares@ US$26.850.0072% mcap5.4% of flowOrdinary sharesSEC144:0001976408-26-000558
4 of 4 declarations
